A vital role for IL-2 trans-presentation in DC-mediated T cell activation in humans as revealed by daclizumab therapy

摘要

While previous studies have described CD25 expression on mature dendritic cells (mDCs) and their production of IL-2, it remains unclear how these molecules participate in the activation of T cells. In search of the mechanisms by which daclizumab, a humanized monoclonal antibody against CD25, inhibits brain inflammation in multiple sclerosis (MS), we observed that while the drug has limited effect on polyclonal T cell activation, it potently inhibits activation of antigen (Ag)-specific T cells by mDCs. We demonstrate that in an Ag-specific manner, mDCs (and Ag-experienced T cells) secrete IL-2 to the mDC-T cell interface and mDCs “lend” their CD25 to primed T cells in trans, in order to facilitate early high affinity IL-2 signaling, which is critical for subsequent T cell expansion and development of Ag-specific effectors. Our data reveal a novel mechanism for the IL-2 receptor system in DC-mediated activation of T cells.